期刊文献+

苯甲酰胺类多巴胺D2受体显像剂^18F-Fallypride的制备和生物分布 被引量:9

Preparation of dopamine D2 receptor imaging agent ^(18)F-Fallypride and biodistribution study in mice
下载PDF
导出
摘要 以(s)-(-)-N-(1-烯丙基吡咯烷-2-氨基甲基)-5-(3-磺酰基)-2,3-二甲氧基苯甲酰胺为氟标记前体,用K222催化进行氟标记,合成了(s)-(-)-N-(1-烯丙基吡咯烷-2-氨基甲基)-5-(3-18F)-2,3-二甲氧基苯甲酰胺(18F-Fallypride)。考察标记物的放化纯度及稳定性,并进行ICR小鼠体内分布特性研究。结果显示,18F-Fallypride的放化产率为40.75%,合成时间40 min,放化纯度大于97%,标记物的生理盐水溶液室温放置4 h,放化纯大于95%。小鼠静脉注射18F-Fallypride后120 min,纹状体/小脑高达14.27。18F-Fallypride进入血液后很快被组织摄取,其中以肾的早期摄取最高(9.91±1.24)%ID.g-1,各脏器的清除均较快(T1/2<1 h),骨的摄取率随时间的延长而增加。 In this paper, we report preparation and biodistribution in mice of ^18F-Fallypride, a doparnine D2 receptor PET imaging agent. ^18F-Fallypride was prepared by nucleophilic fluorination of (s)-N-[(1-allyl-2-pyrrolidinyl)methyl] -5-(3-tolunesulfonyloxypropyl)-2,3-dimethoxybenzamide with K^18F/K222(Kryptofix) in a chemical process control unit. Purity and stability of the ^18F-Fallypride were checked by HPLC and TLC, the dynamic distribution in brain and critical organs of ICR mice were studied. The radiolabelling yield of ^18F-Faliypride was 40.75% and the radiochemistry purity was over 97%. The whole process (including synthesis, purification and analysis) took only 40 minutes. After 4 hours in room temperature, the radiochemical purity of ^18F-Fallypride was still over 95%. The striatum uptake was good, the striatum/cerebellum ratio reached 14.27 at 120 min. Among the critical organs, kidney had the first and the highest uptake (9.91±1.24 %ID·g^-1). All organs had quick clearance (T1/2〈l h). The radioactivity in bone increased with time. The results show that ^18F-Fallypride has a high striatum uptake and a high striatum/ cerebellum ratio, ^18F-Fallypride is a good dopamine D2 receptor agent. The autosynthesis method of ^18F-Fallypride is simple and fast with high labeling yield and high radiochemical purity. This method is fit for clinic use.
出处 《核技术》 CAS CSCD 北大核心 2008年第5期360-363,共4页 Nuclear Techniques
基金 江苏省医学重点人才项目(RC2007096) 江苏省高技术研究计划(BG2006604) 江苏省“六大人才高峰”资助 江苏省卫生厅(200334)资助
关键词 多巴胺D2受体 ^18SF-Fallypride 合成 生物分布 Doparnine D2 receptor, ^18F-Fallypride, Synthesis, Biodistribution
  • 相关文献

参考文献5

二级参考文献9

  • 1De paulis T. The discovery of epidepride and its analogs as high affinity radioligands for imaging extrastriatal dopamine D2 receptors in human brain[J]. Curr Pharm Des, 2003, 9(8): 673-696.
  • 2Mukherjee J, Yang ZY, Brown T, et al. Preliminary assessment of extrastriatal dopamine D2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand,18F-fallypride[J]. Nucl Med Biol, 1999, 26: 519-527.
  • 3Christian BT, narayanan TK, Shi B, et al. Quantitation if striatal and extrastriatal D2 dopamine receptor using PET imaging of [18F]fallypride in nonhuman primates[J]. Synapse,2000, 38: 71-79.
  • 4Mukherjee J, Christian BT, Shi B, et al. Comparison of 18Ffallypride displacement in the thalamus by nicotine-induced and amphetamine-induced dopamine release [J]. J Nucl Med, 2002, 43: 106P.
  • 5Narendran R, Talbot PS, Slifstein M, et al. Effects of d-amphetamine on the binding of 18F-fallypride in striatal and extrastriatal regions in baboons: single bolus and bolus plus constant infusion studies[J]. J Nucl Med, 2002, 43: 106P.
  • 6Mukherjee J, Christian BT, Dunigan KA, et al. Brain imaging of 18F-fallypride in normal volunteers: Blood analysis,distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D2/D3 receptors[J]. Synapse, 2002,46: 170-188.
  • 7Kessler RM, Ansari SM, Li R, et al. Occupancy of striatal and extrastriatal dopamine D2 receptors by atypical antipsychotic drugs[J]. J Nucl Med, 2002, 43: 15.
  • 8Mukherjee J, Christian BT, Narayanan TK, et al. Evaluation of dopamine D2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride[J]. Neuropsychopharmacology, 2001, 25: 476-488.
  • 9杨敏.^(123)I-epidepride:多巴胺D_2受体显像剂[J].国外医学(放射医学核医学分册),2000,24(2):67-70. 被引量:2

共引文献3

同被引文献65

引证文献9

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部